CG Oncology Aktie - CGON

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Current Price

29,13

Gebot

29,11

Fragen

29,19

Volumen

164.488

27,82 Tagesbereich 29,25

25,77 52-Wochen-Bereich 50,23

Marktkapitalisierung

1,97B

Handelsende

28,30

Handelsbeginn

28,06

Letzte Trade

29.1256

Letzter Handelszeitpunkt

19:30:42

Finanzvolumen

US$ 4.711.828

VWAP

28,6454

Durchschnittliches Volumen (3 Mio.)

594.151

Ausgegebene Aktien

67.629.675

Dividendenrendite

Kurs-Gewinn-Verhältnis

-28,91

Gewinn pro Aktie (EPS)

-1

Erlöse

204k

Nettogewinn

-67,8M

CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live ... CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. We see a world where urologic cancer patients can benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. Mehr anzeigen

Sektor

Biological Pds,ex Diagnstics

Branche

Biological Pds,ex Diagnstics

Website

cgoncology.com

Hauptsitz

Dover, Delaware, USA

Gegründet

CG Oncology Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker CGON. The last closing price for CG Oncology was US$28,30. Over the last year, CG Oncology shares have traded in a share price range of US$ 25,77 to US$ 50,23.

CG Oncology currently has 67.629.675 shares in issue. The market capitalisation of CG Oncology is US$1,91 billion. CG Oncology has a price to earnings ratio (PE ratio) of -28.91.

Form 4 - Statement of changes in beneficial ownership of securities

CG Oncology Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

IRVINE, Calif., Dec. 16, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

CG Oncology Announces Pricing of Public Offering

IRVINE, Calif., Dec. 12, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

CG Oncology Announces Proposed Public Offering

IRVINE, Calif., Dec. 11, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (Nasdaq: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone...

SUO-CTC and CG Oncology Announce the First Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award

SCHAUMBURG, Ill. and IRVINE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- The Society of Urologic Oncology Clinical Trials Consortium (SUO-CTC), a national alliance of leading academic and...

Form 8-K - Current report

Groundbreaking Cretostimogene Grenadenorepvec Monotherapy Data Demonstrates Sustained, Durable Complete Responses in High-Risk BCG-Unresponsive Non-Muscle Invasive Bladder Cancer

– 74.5% of patients achieved a complete response at any time – – Median duration of response is greater than 27 months and not reached – – Latest data update continued to show favorable safety...

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0.51	1.7819706499	28.62	29.25	27	920660	28.31373991	CS
4	-5.11	-14.9240654206	34.24	36.73	27	982060	30.49378781	CS
12	-7.01	-19.3967902601	36.14	40.47	27	594151	33.02580161	CS
26	-2.01	-6.45472061657	31.14	40.47	27	656596	34.67243524	CS
52	0.13	0.448275862069	29	50.23	25.77	677893	35.56027599	CS
156	0.13	0.448275862069	29	50.23	25.77	677893	35.56027599	CS
260	0.13	0.448275862069	29	50.23	25.77	677893	35.56027599	CS

CGON - Frequently Asked Questions (FAQ)

What is the current CG Oncology share price?

The current share price of CG Oncology is US$ 29,13

How many CG Oncology shares are in issue?

CG Oncology has 67.629.675 shares in issue

What is the market cap of CG Oncology?

The market capitalisation of CG Oncology is USD 1,91B

What is the 1 year trading range for CG Oncology share price?

CG Oncology has traded in the range of US$ 25,77 to US$ 50,23 during the past year

What is the PE ratio of CG Oncology?

The price to earnings ratio of CG Oncology is -28,91

What is the cash to sales ratio of CG Oncology?

The cash to sales ratio of CG Oncology is 9,66k

What is the reporting currency for CG Oncology?

CG Oncology reports financial results in USD

What is the latest annual turnover for CG Oncology?

The latest annual turnover of CG Oncology is USD 204k

What is the latest annual profit for CG Oncology?

The latest annual profit of CG Oncology is USD -67,8M

What is the registered address of CG Oncology?

The registered address for CG Oncology is 3500 S DUPONT HWY, KENT, DOVER, DELAWARE, 19901

What is the CG Oncology website address?

The website address for CG Oncology is cgoncology.com

Which industry sector does CG Oncology operate in?

CG Oncology operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
AIREreAlpha Tech Corporation	US$ 3,50 (155,47%)	106,79M
SPRCSciSparc Ltd	US$ 0,5069 (129,16%)	220,08M
MGIHMillennium Group International Holdings Ltd	US$ 3,1867 (108,28%)	72,24M
ZCARZoomcar Holdings Inc	US$ 2,74 (91,61%)	56,08M
BCGBinah Capital Group Inc	US$ 3,7795 (90,88%)	7,95M
LNKSLinkers Industries Ltd	US$ 2,54 (-73,51%)	1,57M
BAOSBaosheng Media Group Holdings Ltd	US$ 4,225 (-40,49%)	1,49M
GTIGraphjet Technology	US$ 0,41 (-32,79%)	15,17M
NEUPNeuphoria Therapeutics Inc	US$ 4,79 (-27,75%)	494,76k
SVRESaverOne 2014 Ltd	US$ 1,10 (-27,15%)	1,07M
SPRCSciSparc Ltd	US$ 0,5069 (129,16%)	220,08M
XTIAXTI Aerospace Inc	US$ 0,0404 (3,06%)	197,48M
COEPCoeptis Therapeutics Holdings Inc	US$ 0,211 (48,59%)	192,79M
RGTIRigetti Computing Inc	US$ 14,695 (29,47%)	156,87M
SMXSMX Security Matters Public Company	US$ 0,37585 (72,41%)	155,81M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

CG Oncology Inc (CGON) Börsenkurse

CG Oncology Inc (CGON)

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Über CG Oncology Inc

CGON Neueste Nachrichten

CGON - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen